GSK GB00BN7SWP63

Report

Delayed London Stock Exchange - 11:35 2022-08-10 am EDT
1556.60	GBX		-5.48%

11:02a	European ADRs Climb Higher in Wednesday Trading	MT
05:05a	Exclusive-Rotavirus childhood vaccine shortage hits four African countries	RE
04:59a	Exclusive-Rotavirus childhood vaccine shortage hits four African countries	RE

Summary

Quotes 5-day view Delayed Quote.

Delayed London Stock Exchange

08/04/2022	08/05/2022	08/08/2022	08/09/2022	08/10/2022	Date
1658.4(c)	1667(c)	1659.4(c)	1646.8(c)	1556.6	Last
4 413 895	3 917 789	3 254 908	5 624 487	12 919 214	Volume
-1.10%	+0.52%	-0.46%	-0.76%	-5.48%	Change

More quotes

Estimated financial data (e)

Sales 2022	29 863 M 36 095 M 36 095 M
Net income 2022	4 410 M 5 330 M 5 330 M
Net Debt 2022	15 314 M 18 510 M 18 510 M
P/E ratio 2022	15,2x
Yield 2022	3,48%

Sales 2023	30 498 M 36 863 M 36 863 M
Net income 2023	5 020 M 6 067 M 6 067 M
Net Debt 2023	12 012 M 14 519 M 14 519 M
P/E ratio 2023	13,2x
Yield 2023	3,47%

Capitalization	66 668 M 80 582 M 80 582 M
EV / Sales 2022	2,75x
EV / Sales 2023	2,58x
Nbr of Employees	90 096
Free-Float	93,6%

More Financials

Company

GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also...

Sector

Pharmaceuticals

Calendar

08/18

Ex-dividend day for interim dividend

More about the company

Ratings of GSK plc

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

All news about GSK PLC

11:02a	European ADRs Climb Higher in Wednesday Trading	MT
05:05a	Exclusive-Rotavirus childhood vaccine shortage hits four African countries	RE
04:59a	Exclusive-Rotavirus childhood vaccine shortage hits four African countries	RE
04:24a	ViiV Healthcare Announces Support for Community-Based Organizations With New Monkeypox ..	AQ
04:22a	Exclusive-Rotavirus childhood vaccine shortage hits four African countries	RE
08/08	Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Com..	AQ
08/08	GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker	MT
08/08	GSK plc and IQVIA launch Vaccine Track	CI
08/08	ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help imp..	BU
08/08	UBS Keeps GSK At Neutral, Trims PT	MT
08/08	GSK : Ubs cuts target price to 1820p from 1860p…	RE
08/08	Climate change puts Lyme disease in focus for France's Valneva after COVID blow	RE
08/05	UK Financial Watchdog Fines Ex-ConvaTec Chair For Sharing Inside Information	MT
08/05	GSK : Morgan stanley resumes coverage with equal weight; target p…	RE
08/03	European ADRs Nudge Higher in Wednesday Trading	MT

More news

News in other languages on GSK PLC

11:02a	Les ADR européens montent en flèche dans les échanges de mercredi
05:05a	Exclusif-La pénurie de vaccins infantiles contre le rotavirus frappe quatre pays africa..
04:59a	Exclusif-La pénurie de vaccins infantiles contre le rotavirus frappe quatre pays africa..
04:22a	Exclusif-La pénurie de vaccins infantiles contre le rotavirus frappe quatre pays africa..
08/08	GlaxoSmithKline et IQVIA lancent un outil de suivi des données de vaccination

More news

Analyst Recommendations on GSK PLC

08/08	UBS Keeps GSK At Neutral, Trims PT	MT
07/28	GLAXOSMITHKLINE : Gets a Neutral rating from UBS	MD
07/28	GLAXOSMITHKLINE : Credit Suisse gives a Sell rating	MD

More recommendations

Provided by Scoopnest.com

Analysis

Analysis-As inflation soars, European consumer goods M&A slows